Literature DB >> 26711265

The N Terminus of the Retinoblastoma Protein Inhibits DNA Replication via a Bipartite Mechanism Disrupted in Partially Penetrant Retinoblastomas.

Sergiy I Borysov1, Brook S Nepon-Sixt2, Mark G Alexandrow3.   

Abstract

The N-terminal domain of the retinoblastoma (Rb) tumor suppressor protein (RbN) harbors in-frame exon deletions in partially penetrant hereditary retinoblastomas and is known to impair cell growth and tumorigenesis. However, how such RbN deletions contribute to Rb tumor- and growth-suppressive functions is unknown. Here we establish that RbN directly inhibits DNA replication initiation and elongation using a bipartite mechanism involving N-terminal exons lost in cancer. Specifically, Rb exon 7 is necessary and sufficient to target and inhibit the replicative CMG helicase, resulting in the accumulation of inactive CMGs on chromatin. An independent N-terminal loop domain, which forms a projection, specifically blocks DNA polymerase α (Pol-α) and Ctf4 recruitment without affecting DNA polymerases ε and δ or the CMG helicase. Individual disruption of exon 7 or the projection in RbN or Rb, as occurs in inherited cancers, partially impairs the ability of Rb/RbN to inhibit DNA replication and block G1-to-S cell cycle transit. However, their combined loss abolishes these functions of Rb. Thus, Rb growth-suppressive functions include its ability to block replicative complexes via bipartite, independent, and additive N-terminal domains. The partial loss of replication, CMG, or Pol-α control provides a potential molecular explanation for how N-terminal Rb loss-of-function deletions contribute to the etiology of partially penetrant retinoblastomas.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26711265      PMCID: PMC4760216          DOI: 10.1128/MCB.00636-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  Claspin, a Chk1-regulatory protein, monitors DNA replication on chromatin independently of RPA, ATR, and Rad17.

Authors:  Joon Lee; Akiko Kumagai; William G Dunphy
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

2.  Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage.

Authors:  Dror Avni; Hong Yang; Fabio Martelli; Francesco Hofmann; Wael M ElShamy; Shridar Ganesan; Ralph Scully; David M Livingston
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

3.  MCM2-7 complexes bind chromatin in a distributed pattern surrounding the origin recognition complex in Xenopus egg extracts.

Authors:  Melissa C Edwards; Antonin V Tutter; Christin Cvetic; Catherine H Gilbert; Tatyana A Prokhorova; Johannes C Walter
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

4.  RB reversibly inhibits DNA replication via two temporally distinct mechanisms.

Authors:  Steven P Angus; Christopher N Mayhew; David A Solomon; Wesley A Braden; Michael P Markey; Yukiko Okuno; M Cristina Cardoso; David M Gilbert; Erik S Knudsen
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

5.  A requirement for MCM7 and Cdc45 in chromosome unwinding during eukaryotic DNA replication.

Authors:  Marcin Pacek; Johannes C Walter
Journal:  EMBO J       Date:  2004-08-26       Impact factor: 11.598

Review 6.  Systems for the study of nuclear assembly, DNA replication, and nuclear breakdown in Xenopus laevis egg extracts.

Authors:  C Smythe; J W Newport
Journal:  Methods Cell Biol       Date:  1991       Impact factor: 1.441

7.  A major developmental transition in early Xenopus embryos: I. characterization and timing of cellular changes at the midblastula stage.

Authors:  J Newport; M Kirschner
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

Review 8.  How the other half lives, the amino-terminal domain of the retinoblastoma tumor suppressor protein.

Authors:  David W Goodrich
Journal:  J Cell Physiol       Date:  2003-11       Impact factor: 6.384

9.  Retinoblastoma gene mutations in primary human prostate cancer.

Authors:  Y Kubota; K Fujinami; H Uemura; Y Dobashi; H Miyamoto; Y Iwasaki; H Kitamura; T Shuin
Journal:  Prostate       Date:  1995-12       Impact factor: 4.104

10.  Initiation of DNA replication in nuclei and purified DNA by a cell-free extract of Xenopus eggs.

Authors:  J J Blow; R A Laskey
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

View more
  6 in total

1.  Parent-of-origin effect of hypomorphic pathogenic variants and somatic mosaicism impact on phenotypic expression of retinoblastoma.

Authors:  Valentina Imperatore; Anna Maria Pinto; Elisa Gelli; Eva Trevisson; Valeria Morbidoni; Elisa Frullanti; Theodora Hadjistilianou; Sonia De Francesco; Paolo Toti; Elena Gusson; Gaia Roversi; Andrea Accogli; Valeria Capra; Maria Antonietta Mencarelli; Alessandra Renieri; Francesca Ariani
Journal:  Eur J Hum Genet       Date:  2018-04-17       Impact factor: 4.246

2.  Disruption of CDK-resistant chromatin association by pRB causes DNA damage, mitotic errors, and reduces Condensin II recruitment.

Authors:  Charles A Ishak; Courtney H Coschi; Michael V Roes; Frederick A Dick
Journal:  Cell Cycle       Date:  2017-07-19       Impact factor: 4.534

3.  TGFβ1 Cell Cycle Arrest Is Mediated by Inhibition of MCM Assembly in Rb-Deficient Conditions.

Authors:  Brook S Nepon-Sixt; Mark G Alexandrow
Journal:  Mol Cancer Res       Date:  2018-09-26       Impact factor: 5.852

4.  Peptide-tiling screens of cancer drivers reveal oncogenic protein domains and associated peptide inhibitors.

Authors:  Kyle M Ford; Rebecca Panwala; Dai-Hua Chen; Andrew Portell; Nathan Palmer; Prashant Mali
Journal:  Cell Syst       Date:  2021-05-28       Impact factor: 11.091

5.  Multiple molecular interactions redundantly contribute to RB-mediated cell cycle control.

Authors:  Michael J Thwaites; Matthew J Cecchini; Srikanth Talluri; Daniel T Passos; Jasmyne Carnevale; Frederick A Dick
Journal:  Cell Div       Date:  2017-03-14       Impact factor: 5.130

Review 6.  The Human Replicative Helicase, the CMG Complex, as a Target for Anti-cancer Therapy.

Authors:  Yeon-Soo Seo; Young-Hoon Kang
Journal:  Front Mol Biosci       Date:  2018-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.